Delivery Order SPE2DB25D3017-SPE2DB26FVGVG
- Not listed
- The Defense Logistics Agency awarded a $1,951.95 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen auto-injectors on October 30, 2025, with completion targeted for October 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to the company's corporate headquarters in...
- The Defense Logistics Agency awarded a $6,561.71 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen injectors on June 24, 2025, with completion targeted for June 25, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $1,626.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen auto-injectors on June 9, 2025. This non-set-aside contract, effective through June 10, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $2,026.98. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract is scheduled for completion by October 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- The Defense Logistics Agency awarded a $3,419.13 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml). This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award carries no set-aside designation and reflects...
- The Defense Logistics Agency awarded a $1,878.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 19, 2025, with completion scheduled for August 20, 2025. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections with a ceiling value of $3,883.38. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 16,...
- The Defense Logistics Agency awarded a $10,424.59 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen auto-injectors on September 29, 2025, with completion scheduled for September 30, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,288.63 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pen auto-injectors on August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed price, non-set-aside competitively awarded delivery order executed from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $26,135.43 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors on September 2, 2025, with completion expected by September 3, 2025. This contract is issued under a firm fixed-price arrangement with no set-aside designation, representing a competitively awarded delivery order. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB26FVGVGDelivery Order
The Defense Logistics Agency awarded a $6,898.33 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen auto-injectors on October 30, 2025, with completion scheduled for October 31, 2025. This firm fixed price contract, placed without a set-aside designation, represents a competitively awarded order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical vendor for federal military and veteran healthcare systems, supplying a comprehensive range of medications and medical supplies through its DLA contract portfolio. The Trulicity delivery—a diabetes management medication—exemplifies the company's role in supporting the Defense Health Agency and other government healthcare programs. As a major pharmaceutical distributor and prime contractor under DLA's Pharmaceutical Prime Vendor Global Program, AmerisourceBergen demonstrates the operational capacity and regulatory compliance necessary to fulfill federal medical procurement requirements across multiple therapeutic domains on a global scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 10/30/25 |